- Home
- NUVB vs VTOL Comparison
NUVB vs VTOL Comparison
Compare NUVB & VTOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- VTOL
- Stock Information
- Founded
- NUVB 2018
- VTOL N/A
- Country
- NUVB United States
- VTOL United States
- Employees
- NUVB N/A
- VTOL N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- VTOL Transportation Services
- Sector
- NUVB Health Care
- VTOL Consumer Discretionary
- Exchange
- NUVB Nasdaq
- VTOL Nasdaq
- Market Cap
- NUVB 837.0M
- VTOL 994.8M
- IPO Year
- NUVB N/A
- VTOL N/A
- Fundamental
- Price
- NUVB $3.89
- VTOL $37.79
- Analyst Decision
- NUVB Strong Buy
- VTOL
- Analyst Count
- NUVB 6
- VTOL 0
- Target Price
- NUVB $8.00
- VTOL N/A
- AVG Volume (30 Days)
- NUVB 6.2M
- VTOL 160.0K
- Earning Date
- NUVB 11-05-2025
- VTOL 11-04-2025
- Dividend Yield
- NUVB N/A
- VTOL N/A
- EPS Growth
- NUVB N/A
- VTOL 268.18
- EPS
- NUVB N/A
- VTOL 3.99
- Revenue
- NUVB $14,355,000.00
- VTOL $1,445,607,000.00
- Revenue This Year
- NUVB $332.80
- VTOL $10.77
- Revenue Next Year
- NUVB $360.12
- VTOL $9.31
- P/E Ratio
- NUVB N/A
- VTOL $9.47
- Revenue Growth
- NUVB 900.35
- VTOL 4.01
- 52 Week Low
- NUVB $1.54
- VTOL $25.11
- 52 Week High
- NUVB $4.09
- VTOL $39.32
- Technical
- Relative Strength Index (RSI)
- NUVB 83.37
- VTOL 54.16
- Support Level
- NUVB $2.87
- VTOL $36.54
- Resistance Level
- NUVB $3.08
- VTOL $38.78
- Average True Range (ATR)
- NUVB 0.22
- VTOL 0.95
- MACD
- NUVB 0.08
- VTOL -0.18
- Stochastic Oscillator
- NUVB 86.52
- VTOL 52.74
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.